Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Yu

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Critical Care (London, England)|August 12, 2021
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trialJean-François Timsit, Jennifer A Huntington, Richard G Wunderink, et al.
BMC Biology|December 16, 2022
Construction and characterization of a genome-scale ordered mutant collection of Bacteroides thetaiotaomicronHeidi A Arjes, Jiawei Sun, Hualan Liu, et al.
Oncogenesis|January 20, 2026
Cytoskeleton reorganization induced by a novel K6-K14 keratin fusion promotes cancer stemness and cellular plasticity via cGAS-STING selectionI-Hsuan Chen, Senthilkumar Ravichandran, Ming-Tsung Lai, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Prolonged delays in human microbiota transmission after a controlled antibiotic perturbationKatherine S Xue, Sophie Jean Walton, Doran A Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2025
Safety and Efficacy of Tarlatamab in patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 StudyRahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier, et al.
BMC Cancer|June 21, 2023
Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiationBrian Yu, Sung Jun Ma, Michael Khan, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2022
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumoniaIgnacio Martin-Loeches, Jean-François Timsit, Marin H Kollef, et al.
Cell Host & Microbe|September 2, 2021
Quantifying rapid bacterial evolution and transmission within the mouse intestineKimberly S Vasquez, Lisa Willis, Nate J Cira, et al.
Cell Host & Microbe|January 20, 2022
Establishment and characterization of stable, diverse, fecal-derived in vitro microbial communities that model the intestinal microbiotaAndrés Aranda-Díaz, Katharine Michelle Ng, Tani Thomsen, et al.
Cell Host & Microbe|November 15, 2019
Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental ReservoirsKatharine Michelle Ng, Andrés Aranda-Díaz, Carolina Tropini, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Critical Care (London, England)|August 12, 2021
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trialJean-François Timsit, Jennifer A Huntington, Richard G Wunderink, et al.
BMC Biology|December 16, 2022
Construction and characterization of a genome-scale ordered mutant collection of Bacteroides thetaiotaomicronHeidi A Arjes, Jiawei Sun, Hualan Liu, et al.
Oncogenesis|January 20, 2026
Cytoskeleton reorganization induced by a novel K6-K14 keratin fusion promotes cancer stemness and cellular plasticity via cGAS-STING selectionI-Hsuan Chen, Senthilkumar Ravichandran, Ming-Tsung Lai, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Prolonged delays in human microbiota transmission after a controlled antibiotic perturbationKatherine S Xue, Sophie Jean Walton, Doran A Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2025
Safety and Efficacy of Tarlatamab in patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 StudyRahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier, et al.
BMC Cancer|June 21, 2023
Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiationBrian Yu, Sung Jun Ma, Michael Khan, et al.
The Journal of Antimicrobial Chemotherapy|January 13, 2022
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumoniaIgnacio Martin-Loeches, Jean-François Timsit, Marin H Kollef, et al.
Cell Host & Microbe|September 2, 2021
Quantifying rapid bacterial evolution and transmission within the mouse intestineKimberly S Vasquez, Lisa Willis, Nate J Cira, et al.
Cell Host & Microbe|January 20, 2022
Establishment and characterization of stable, diverse, fecal-derived in vitro microbial communities that model the intestinal microbiotaAndrés Aranda-Díaz, Katharine Michelle Ng, Tani Thomsen, et al.
Cell Host & Microbe|November 15, 2019
Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental ReservoirsKatharine Michelle Ng, Andrés Aranda-Díaz, Carolina Tropini, et al.
Pageof 10